The great immune escape: understanding the divergent immune response in breast cancer subtypes

SS Onkar, NM Carleton, PC Lucas, TC Bruno… - Cancer …, 2023 - aacrjournals.org
Breast cancer, the most common type of cancer affecting women, encompasses a collection
of histologic (mainly ductal and lobular) and molecular subtypes exhibiting diverse clinical …

Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the international …

S Hendry, R Salgado, T Gevaert… - Advances in anatomic …, 2017 - journals.lww.com
Assessment of tumor-infiltrating lymphocytes (TILs) in histopathologic specimens can
provide important prognostic information in diverse solid tumor types, and may also be of …

[HTML][HTML] Tissue-resident FOLR2+ macrophages associate with CD8+ T cell infiltration in human breast cancer

RN Ramos, Y Missolo-Koussou, Y Gerber-Ferder… - Cell, 2022 - cell.com
Macrophage infiltration is a hallmark of solid cancers, and overall macrophage infiltration
correlates with lower patient survival and resistance to therapy. Tumor-associated …

Breast tumor microenvironment structures are associated with genomic features and clinical outcome

E Danenberg, H Bardwell, VRT Zanotelli… - Nature …, 2022 - nature.com
The functions of the tumor microenvironment (TME) are orchestrated by precise spatial
organization of specialized cells, yet little is known about the multicellular structures that …

[HTML][HTML] The tumor-derived cytokine Chi3l1 induces neutrophil extracellular traps that promote T cell exclusion in triple-negative breast cancer

T Taifour, SS Attalla, D Zuo, Y Gu… - Immunity, 2023 - cell.com
In triple-negative breast cancer (TNBC), stromal restriction of CD8+ T cells associates with
poor clinical outcomes and lack of responsiveness to immune-checkpoint blockade (ICB). To …

Tumor-infiltrating lymphocytes and prognosis: a pooled individual patient analysis of early-stage triple-negative breast cancers

S Loi, D Drubay, S Adams, G Pruneri… - Journal of clinical …, 2019 - ascopubs.org
Purpose The aim of the current study was to conduct a pooled analysis of studies that have
investigated the prognostic value of tumor-infiltrating lymphocytes (TILs) in early-stage triple …

Atezolizumab and nab-Paclitaxel in Advanced Triple-Negative Breast Cancer: Biomarker Evaluation of the IMpassion130 Study

LA Emens, L Molinero, S Loi, HS Rugo… - JNCI: Journal of the …, 2021 - academic.oup.com
Background Understanding the impact of the tumor immune microenvironment and
BRCA1/2-related DNA repair deficiencies on the clinical activity of immune checkpoint …

Fibroblast heterogeneity and immunosuppressive environment in human breast cancer

A Costa, Y Kieffer, A Scholer-Dahirel, F Pelon… - Cancer cell, 2018 - cell.com
Carcinoma-associated fibroblasts (CAF) are key players in the tumor microenvironment.
Here, we characterize four CAF subsets in breast cancer with distinct properties and levels …

Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis

P Savas, B Virassamy, C Ye, A Salim, CP Mintoff… - Nature medicine, 2018 - nature.com
The quantity of tumor-infiltrating lymphocytes (TILs) in breast cancer (BC) is a robust
prognostic factor for improved patient survival, particularly in triple-negative and HER2 …

Spatially distinct tumor immune microenvironments stratify triple-negative breast cancers

T Gruosso, M Gigoux, VSK Manem, N Bertos… - The Journal of clinical …, 2019 - jci.org
Understanding the tumor immune microenvironment (TIME) promises to be key for optimal
cancer therapy, especially in triple-negative breast cancer (TNBC). Integrating spatial …